Aclaris Therapeutics, Inc. (0H8T)
Market Closed
12 Jun, 15:30
LSE 
$
4. 41
+0.26
+6.3908%
$
- Market Cap
- P/E Ratio
- Div Yield
2,030 Volume
-1.64 Eps
$ 4.14
Previous Close Want to track 0H8T and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Aclaris Therapeutics, Inc. (0H8T) Statistics
Valuation metrics
Market Cap -
Enterprise value 499.12M
Trailing P/E (ttm) -8.06
Forward P/E -
PEG ratio -0.15
Price/Sales (ttm) 62.84
Price/Book (mrq) 3.91
Enterprise Value/Revenue 59.65
Enterprise Value/EBITDA -6.83
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 1.42K
Average volume (90 days) 10.94K
Price summary
52-Week low 1.36
52-Week high 5.15
Beta -
50-Day moving average 4.53
200-Day moving average 3.62
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -8.33%
Operating margin -9.62%
Operational effectiveness
Return on assets -0.35%
Return on equity -0.56%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) 0.06
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -0.54
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 0.82
Total debt (mrq) -
Total Debt/Equity (mrq) 0.01
Current ratio (mrq) 4.03%
Book value per share (mrq) 1.12
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
